Swift Run Capital Management’s Amgen AMGN Stock Holding History

Swift Run Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$306K	Hold	1,333	–	–	0.59%	36
2020 Q3	$339K	Hold	1,333	–	–	0.67%	34
2020 Q2	$314K	Hold	1,333	–	–	0.52%	41
2020 Q1	$270K	Buy	+1,333	New	+$291K	0.38%	47
2015 Q3	–	Sell	-2,752	Closed	-$422K	–	52
2015 Q2	$422K	Hold	2,752	–	–	0.18%	40
2015 Q1	$440K	Buy	+2,752	New	+$433K	0.19%	40
2014 Q4	–	Sell	-2,985	Closed	-$419K	–	46
2014 Q3	$419K	Hold	2,985	–	–	0.22%	36
2014 Q2	$353K	Hold	2,985	–	–	0.15%	39
2014 Q1	$368K	Buy	2,985 +34	+1%	+$4.12K	0.2%	37
2013 Q4	$337K	Buy	+2,951	New	+$336K	0.27%	37

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Swift Run Capital Management's AMGN Position: Q4 2020 in Review

Swift Run Capital Management held its Amgen (AMGN) position steady in Q4 2020 at 1,333 shares worth $306K. The position accounts for 0.59% of the portfolio, ranked #36.

Swift Run Capital Management first reported a position in AMGN in Q4 2013 and has held it in 10 quarters since. The position peaked at $440K in Q1 2015. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Swift Run Capital Management held 1,333 shares of Amgen worth $306K as of Q4 2020.
Swift Run Capital Management left its Amgen share count unchanged in Q4 2020.
Amgen made up 0.59% of Swift Run Capital Management's portfolio in Q4 2020, its #36 holding.
Swift Run Capital Management first reported a position in Amgen in Q4 2013 and has held it in 10 quarters since.
Swift Run Capital Management's Amgen position peaked at $440K in Q1 2015.
2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Swift Run Capital Management's 13F filing for Q4 2020, filed 2 Feb 2021.